sydnexis crl fda_thumbnail
October 28, 2025

Sydnexis Receives FDA Complete Response Letter for SYD-101 Pediatric Myopia Treatment

It’s not the “yes” Sydnexis hoped for…but it’s not a “no,” either.  The U.S. Food and Drug Administration (FDA) has…

Discover our fascinating content at issuu

explore